Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Increased androgen receptor expression in certain hair follicle areas may cause male pattern baldness.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Early hormones shape sex-specific differences in rat glands.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Chromosomal differences affect how muscle cells respond to testosterone.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Sebocytes play a key role in controlling androgen levels in human skin.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

VEGF and its receptor might cause hair loss.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.